



Are ECG abnormalities common in black 
Africans with heart failure? 
Results from the Heart of Soweto study 
INTRODUCTION                                                                  
Heart failure (HF) is a deadly and debilitating clinical syndrome that is 
the fi nal and common pathway of numerous cardiovascular disease 
(CVD) states.(1) Preliminary data from the Heart of Soweto study (one 
of the largest studies of heart disease in Africa)(2) support the 
proposition that the phenomenon of epidemiologic transition and the 
subsequent emergence of more affl uent forms of CVD seen in high 
income countries has broadened the pathways to the syndrome and 
increased the pool of affected individuals.(3)
In sub-Saharan Africa, HF has traditionally been caused by untreated 
rheumatic heart valvular disease, idiopathic and peripartum 
cardiomyopathy and hypertension.(4,5) 
A particularly striking problem in this context is the usually late 
presentation of cases (i.e. where the antecedents to the syndrome have 
typically remained untreated, leading to clinically advanced forms of 
HF). The case in support of early detection and preventative treatment 
strategies is particularly strong in Soweto.  However, those still imperfect 
strategies used to detect HF in high income countries, including 
systematic screening with brain natriuretic peptide assays(6) and rapid 
access echocardiography(7) may prove to be too costly and impractical 
in low to middle income countries such as South Africa. 
A potentially cheap and useful diagnostic tool to detect HF in a relatively 
small number of adults living in large communities in low to middle 
income countries is the 12-lead electrocardiogram (ECG). Despite 
being “old” technology and commonly regarded as inferior to newer, 
more costly, technologies, the ECG still plays an important role in the 
clinical assessment of patients with CVD.  The ECG provides information 
on the heart’s position within the chest, electrical disturbances and 
electrolyte disturbances. Furthermore, it shows the mass of cardiac 
muscle and indicates the presence of ischemic changes refl ecting 
possible coronary artery disease (CAD) or ventricular dysfunction. 
Many different tools have been developed to assess the 12-lead ECG, 
including Cornell voltage, Sokolow-Lynn voltage and Romhilt-Estes 
indices.(8-10) However, some authors have reported concerns with 
sensitivity and specifi city.(9) In particular, the voltage indices show 
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 Background: The “Heart of Soweto” 
study is currently examining the pattern of cardiovascular 
disease (CVD) in Soweto, South Africa. 
Methods: As part of a large clinical registry of CVD patients 
presenting to the Chris Hani Baragwanath Hospital in 
Soweto, a 12-lead ECG was performed on 91% of 
“de novo” cases in 2006. Systematic analysis of the ECGs of 
heart failure patients was performed using detailed 
Minnesota coding.
Results: A total of 756 de novo patients with HF (57% 
women, 88% Black African and mean age of 55 ± 16 years) 
had a 12-lead ECG. Overall, a major ECG abnormality was 
detected in 91% of cases consisting of ST segment changes, 
T wave changes, bundle branch blocks and arrhythmias. 
Minor abnormalities were noted in 97% of ECGs, such as 
axis deviation and high amplitude R waves. Left ventricular 
hypertrophy was evident in 15% (22% in those with a dilated 
cardiomyopathy) and a bundle branch block in 8% of ECGs 
(11% in those with an ischemic cardiomyopathy). 
Conclusion: Detailed examination of 12-lead ECGs of a 
large group of previously undiagnosed patients with HF in 
the Heart of Soweto study revealed many identifi able 
abnormalities. In addition to reconfi rming the clinical 
utility of this cheap and practical diagnostic tool, these data 
highlight its potential role in screening for heart disease, 
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differing results in determining LVH in an African-American 
population.(8) 
In the presence of HF, there are particular abnormalities identifi ed from 
the ECG that can characterize the syndrome, such as conduction 
abnormalities (e.g. bundle branch blocks, high amplitude R waves 
indicating hypertrophy and wide QRS complexes).(7) Indeed, one recent 
report from predominantly Caucasian populations living in high income 
countries indicated that over 90% of those with HF had an abnormal 
ECG.(7)
STUDY AIMS                                                                       
The primary aim of this study was to undertake a preliminary analysis 
of ECG data derived from a large cohort of Black African patients with 
HF (confi rmed by echocardiography) within the 2006 Heart of Soweto 
study cohort to determine the concurrent prevalence and type of 
major and minor ECG abnormalities. Ultimately, these data will be used 
to evaluate the role of 12-lead ECGs in detecting previously undiagnosed 
HF in this setting.
METHODS                                                                            
Participants & Setting
As previously described in more detail, the Heart of Soweto study was 
established to investigate the prevalence and incidence of CVD within 
the townships of Soweto, South Africa.(2) As part of this study, we have 
systematically examined the volume, spectrum and pattern of clinical 
presentations in those attending the Cardiology Unit of the Chris Hani 
Baragwanath Hospital. The hospital provides health care to the 
estimated 1 to 1.5 million predominantly black Africans residing in the 
adjacent townships of Soweto. The study was approved by the hospital’s 
Ethics of Human Research Committee.
As described in our index report from the Heart of Soweto study,(11) 
all fi rst-time patients diagnosed with HF presenting to Chris Hani 
Baragwanath Hospital between the 1st January to 31st December 2006 
were subject to a combination of echocardiographic assessment and 
review by a supervising cardiologist, in either the cardiac clinic or 
Coronary Care Unit. Only patients with confi rmed HF (see diagnostic 
criteria below) were included in the study. This comprises a total of 844 
patients with a combination of symptoms of HF and objective evidence 
of cardiac dysfunction (systolic and/or diastolic) at rest.  As indicated 
above, all patients included in this report were subject to 
echocardiographic assessment with detailed assessment of ventricular 
function, valvular integrity and function and regional wall abnormalities 
(specifi c measurements were available in all but 41 cases [5%]). 
Specifi cally, two-dimensional targeted M-mode echocardiography with 
Doppler colour fl ow mapping was performed using a Hewlett Packard 
Sonos 5 500 echocardiograph attached to a 2.5 or 3.5 MHz transducer. 
All echocardiographic procedures were undertaken by trained 
operators and measurements were made according to the American 
Society of Echocardiography guidelines.(12) Diastolic mitral fl ow was 
assessed by pulsed-wave Doppler echocardiography from the apical 
four-chamber view. The E wave deceleration time was also measured as 
the interval between the peak early diastolic velocity and the point at 
which the steepest deceleration slope is extrapolated to the zero line. 
A detailed cardiac assessment was performed by a qualifi ed or trainee 
Cardiologist to document lung and heart sounds and other clinically 
signifi cant signs and symptoms. Functional status was also assessed to 
determine New York Heart Association Classifi cation of dyspnea.(13) 
Clinical classifi cation
All cases were reviewed by SS and KS. These are based on European 
Society of Cardiology current guidelines(13) and the recently published 
European Heart Survey.(14) Based on the above process, the research 
team documented a clinical diagnosis for every individual included in 
the registry and captured close to 100% of their basic socio-economic 
and clinical profi le from the standardized interview and assessments. 
The following forms of HF were identifi ed as part of the clinical review 
process:
Left ventricular systolic dysfunction
Left ventricular ejection fraction (LVEF) < 45%.
Diastolic dysfunction
Classifi ed based on E/A ratio and deceleration time according to 
generally accepted criteria.(12)
Dilated cardiomyopathy
LVEF ≤ 45% and Left Ventricular Dimension in Diastole > 55 mm 
with global regional wall motion abnormality.
Ischemic cardiomyopathy
LVEF < 45%, confi rmed diagnosis of CAD and regional wall motion 
abnormality.
Hypertensive heart failure
Blood pressure of > 180/100 mmHg accompanied by symptoms 
of HF (dyspnea and tachycardia), increased LV septal thickness 
(> 1.3 mm), diastolic dysfunction and/or systolic dysfunction (LVEF 







Secondary to primary underlying valve disease (e.g. rheumatic 
heart disease or degenerative valve disease) as opposed to 
underlying valvular dysfunction (e.g. mitral regurgitation) due to 
underlying cardiac dysfunction/failure.
Right heart failure
Secondary to right-sided pathophysiology with increased jugular 
venous pressure and liver size, tricuspid regurgitation and elevated 
right ventricular systolic pressure > 35 mmHg. Usually accompanied 
by peripheral oedema as unique or concomitant to left ventricular 
failure. 
Other forms of heart failure
That includes congenital heart disease with delayed diagnosis made 
only in adulthood, hypertrophic obstructive cardiomyopathy, 
endomyocardial fi brosis, sub-mitral aneurysm, and secondary to 
infectious pericardial effusion. 
On confi rmation of the presence of HF, detailed clinical records were 
completed, including demographic data (age, race and sex with socio-
demographic profi le) and clinical data (encompassing blood pressure, 
anthropometric measurements, self-reported cardiac risk factors, 
functional status for angina and breathlessness). All patients were given 
a unique identifying code to allow further data analyses using the clinical 
registry. The total number of new “de novo” HF cases seen by the 
Cardiology Unit of the Chris Hani Baragwanath Hospital in the calendar 
year 2006 was 844. Of these, 756 (90%) had a documented 12-lead 
ECG that was entered into the clinical registry with a hard copy available 
for detailed analyses.
ECG analysis
A 12-lead resting ECG was performed by a trained technician and 
analysed by blinded reviewers (clinical cardiac nurses with advanced 
training) using the Minnesota Code Classifi cation system.(15) Some had 
undertaken post-graduate diplomas in cardiac nursing and all worked 
in clinical nursing positions within cardiology. Two cardiac trained 
nurses (SS & GL) then independently verifi ed these ECGs. The code 
allows systematic classifi cation of Q and QS patterns, axis deviation, 
R waves, ST depression and elevation and T wave changes, along with 
conduction abnormalities in both atria and ventricles.(15,16) In addition 
to the Minnesota code, we also examined P wave changes (that is, left, 
right and biatrial changes that refl ect atrial hypertrophy).
The abnormalities detected by the Minnesota code were pooled into 




for ST segment depression, arrhythmias or AV blocks, bundle branch 
blocks and left axis deviation. The rationale for major and minor 
abnormalities was based primarily on a previous study by De Bacquer 
and colleagues(17) and the lack of consenses in other studies regarding 
the classifi cation of ECG abnormalities.(9,10) (18-20) Also, there are potential 
clinical advantages in dividing ECG abnormalities into major and minor 
changes. The relevant Minnesota codes for each abnormality group are 
presented in Table 1. 
Major abnormalities were defi ned as those with Q wave abnormalities, 
ST segment depression, T wave inversion, complete or second degree 
AV block, complete left or right bundle branch block (LBBB, RBBB), 
frequent premature beats, atrial fi brillation or fl utter. Those with minor 
abnormalities were defi ned as borderline Q waves, left or right axis 
deviation, high amplitude R waves, borderline ST segment depression, 
T wave fl attening and low QRS voltage. Sinus tachycardia was defi ned 




TABLE 1: Defi nition of ECG abnormalities and corresponding Minnesota codes(14) 
Major abnormalities
Q and QS patterns (indicating myocardial  Code I1-2
infarction) 
ST depression (Anterolateral, posterior,  Codes IV1-2
anterior)   
Negative T waves Codes V1-2
Heart block Codes VI1-2
(Wenckebach, Partial, Mobitz type II, 
complete heart block) 
Ventricular conduction defects  Codes VII1-2
(Bundle branch block – complete or 
intermittent)
Arrthymias  Codes  VIII1-3
(Premature atrial or ventricular beats, 
atrial/ventricular fi brillation or fl utter)
Minor abnormalities
Borderline Q wave abnormalities Code I3
Axis Deviation (left or right) Codes II1-2
High amplitude R waves Code III1-2
ST segment downward sloping Code IV3
Flattened T waves Code V3
Low QRS voltage Code IX1
Other abnormalities
Ischemic fi ndings Codes I3 or IV1-3 or V1-3 or VII1
ST depression Codes IV1-3
Arrhythmias Codes VIII1-6 or VII1-2, 4
Bundle branch blocks Codes VII1-2, 4
Left ventricular hypertrophy Codes III1 and (IV1-3 or V1-3)
Left axis deviation Codes II1
ECG Abnormality Minnesota Code
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Data analysis
Simple frequency and correlational analyses of ECG abnormalities 
according to the underlying type of HF were performed using SPSS 
version 13. 
RESULTS                                                                               
Clinical & Demographic Profi le 
Of the 756 patients with a confi rmed diagnosis of HF in the study 
cohort, 57% (n=478) were female, 88% (n=665) were black African 
and their mean age was 55 years (± 16 years). More than one 
recognizable HF antecedent was evident in over 90% of the sample, 
with 70% having hypertension, 47% being smokers and 34% being 
obese. The mean LVEF was 45 ± 18% with 27% presenting with diastolic 
dysfunction (the majority had preserved systolic function). Five 
predominant forms of HF were identifi ed in this cohort: dilated 
cardiomyopathy (CMO) (n=251, 35%), hypertensive HF (n=242, 33%), 
right HF (n=193, 27%), valvular HF (n=49, 8%) and ischemic CMO 
(n=65, 9%). Black Africans were far more likely to present with a dilated 
CMO (OR 4.39, 95% CI 2.41 to 8.00) but far less likely to present with 
ischemic CMO (OR 0.11, 95% CI 0.07 to 0.19). Patients with dilated 
CMO (7% and 12%) and right HF (10% and 40%) were most likely to 
have moderate to severe mitral or tricuspid regurgitation.
Major and minor abnormalities
When applying Minnesota coding of each patient’s 12-lead ECG, major 
ECG abnormalities (refer to Table 1) were recorded in 91% of HF 
patients. The most notable major abnormality was negative T waves in 
57% of ECGs (n= 428) – refer to Figure 1. Other common abnormalities 
were ST segment depression in 21% (n=159) followed by Q waves in 
18% (n=135). Only 3% of ECGs were normal. 
Most ECGs indicated that patients were in sinus rhythm (n=475, 63%) 
or sinus tachycardia (n=198, 26%). A small number of patients (n = 13, 
2%) had a heart rate < 50 bpm. A further 41 patients (5%) showed left 
anterior hemiblock and eight ECGs demonstrated intraventricular 
block. A close examination of P wave morphology revealed a left atrial 
abnormality in 100 patients (13%) and a further 93 ECGs (12%) 
demonstrated right atrial abnormality. Biatrial abnormality was evident 
in 60 ECGs (8%). In relation to the examination of AV conduction 
defects, three patients had an ECG suggesting a complete heart block, 
one patient a Mobitz heart block and two patients had pacemakers 
with appropriate capture. Three ECGs revealed a shortened PR 
interval, while 34 (4.4%) revealed a prolonged PR interval. A total of 
64 patients (8%) were in atrial fi brillation or atrial fl utter. Of these, 
52 ECGs demonstrated persistent AF /persistent atrial fl utter, with the 
remainder demonstrating intermittent AF.
A total of 97% of ECGs demonstrated minor ECG abnormalities (refer 
to Figure 2). Of these, the most common were axis deviation and high 
R wave amplitude (n=232, 31%), followed by fl attened T waves in 24% 
of ECGs (n=179). Borderline ST segment depression (downward 
sloping ST segments) and borderline Q waves were observed in 48 
ECGs (6%). Low QRS voltage was also recorded in 5% of ECGs 
(n=37).









































































8ECG characteristics indicating possible HF
Specifi c characteristics that can be detected on a 12-lead ECG that are 
an indicator of HF include left ventricular hypertrophy (LVH), bundle 
branch blocks and axis deviation. Given that LVH is often associated 
with the development of HF (particularly in hypertensive individuals), it 
was interesting to note that ECG evidence of LVH was coded in 15% 
of this patient cohort (n=110). This was based on a Minnesota coding 
of isolated high amplitude R wave (code III1) and either ST elevation 
(code IV 1-3) or T wave changes (code V 1-3).
(15)  Overall, LVH was 
observed in the ECGs of 54 patients with a dilated CMO (49%), 35 
patients with hypertensive CMO (32%) and 22 of those with right HF 
(20%). In contrast, only four patients diagnosed with an ischemic CMO 
(3.6%) had ECG evidence of LVH (p < 0.001 for the comparison to all 
other diagnostic groups).  
Figure 3 highlights the abnormalities typically observed on an ECG in a 
person with heart failure. It highlights tall R waves, ST segment changes 
and inverted T waves. All of these characteristics substantiate the 
probability of underlying LVH.  
Bundle branch blocks are associated with HF and ventricular dysynchrony 
resulting in a decrease in cardiac output, adding to the already 
overburdened heart. With respect to ventricular conduction defects, 
(namely bundle branch blocks), a total of 32 ECGs (4%) had complete 
LBBB and 11 (1.5%) had RBBB. A further 13 (1.8%) had incomplete/
intermittent RBBB and 14 (1.8%) had incomplete left bundle branch 
blocks.
Although the majority of ECG axes were normal (n=511), 130 (17%) 
indicated a right axis deviation and 107 (14%) a left axis deviation (see 
Table 2). 
DISCUSSION                                                                       
Examination of the ECG data on de novo HF presentations in the 
Heart of Soweto study revealed a high prevalence of ECG abnormalities. 
Specifi cally, we found that Minnesota coding of 12-lead ECGs revealed 
major and minor abnormalities in 91% and 97% of patients, respectively. 
As such, only 3% of ECGs were normal. Other ECG characteristics that 
are associated with HF (although these can also present with other 
pathologies) were shown in 8% of ECGs demonstrating bundle branch 
block, 15% with characteristics of LVH and a further 31% of ECGs had 
axis deviation. Thus the ECG plays a potentially important role in 
identifying abnormalities that are connected to a diagnosis of HF in 
ECG ABNORMALITIES 
IN HEART FAILURE
FIGURE 3:  An example of a 12-lead electrocardiogram from a 45-year-old black South African female with hypertensive cardiomyopathy illustrating tall R waves, ST segment and T wave 
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this clinical setting of predominantly urban dwelling black Africans in 
South Africa.
In the present study, the majority of ECGs were abnormal. This was not 
surprising, however, since HF is the end result of poor cardiovascular 
health, which other conditions predispose the development of. The high 
number of abnormalities is in total agreement with previous studies 
that detected anomalies in the majority of ECGs of HF patients,(17,18) 
with one study reporting abnormal ECGs in 97% of patients.(17) 
The general consensus is that the ECG, in conjunction with patient 
symptoms, has an important role in guiding therapy and provides a 
basis for further investigation, that most likely being echocardiography.(18,19) 
It is also important to recognize that abnormal ECG fi ndings strongly 
suggest the presence of abnormal cardiac functioning which, if left 
unmonitored and untreated, can lead to a diagnosis of HF. 
Whilst a large number of HF patients had abnormal ECGs, more 
specifi c indications of HF from the ECG were detected in a smaller 
number of individuals. Overall, any ECG characteristic associated with 
HF (LVH, bundle branch blocks and axis deviation) were found in a 
total of 362 patients (48%). In comparison to the few studies in the 
literature that report the proportions of HF patients with ECG 
characteristics of HF, the number of LBBB observed on the ECGs in the 
current study was approximately one-third of that reported in other 
studies.(20,21) This discrepancy may be explained by the multiplicity of 
etiologies that can drive the development of HF (in this context from 
chronic hypertension to right heart failure to idiopathic CMOs). As 
such, in this cohort, in contrast to studies undertaken in high income 
countries where atherosclerotic disease predominates, ischemic CMO 
was the exception rather than the rule.(11)
There are many choices in determining an ECG classifi cation tool. We 
chose to apply the Minnesota code to detect ECG abnormalities 
because it has been well validated, it is applicable to most populations 
compared to other indices(8) and, most importantly, it encapsulates the 
major ECG abnormalities that are important in describing an individual’s 
electrophysiological function. A recent systematic review concluded that 
alternative electrocardiography indices deemed useful for detecting LV 
hypertension (Sokolow-Lyon index, Cornell voltage index, Cornell 
product, Gubner and Romhilt-Estes scores) suffered from poor 
accuracy.(9) Also, the amplitude of the signal voltage on ECGs poorly 
predicted LVH.(10) Finally, the Minnesota code has commonly been 
employed as a “prognostic” tool to determine long-term health out-
comes and is associated with all-cause and CVD mortality.(8-10, 17, 22-24)
As an alternative marker of underlying ventricular dysfunction, brain 
natriuretic peptide (BNP) is a biochemical marker also used to detect 
HF and recommended to be used in conjunction with the ECG.(6) BNP 
is strongly related to the diagnosis of chronic heart failure (CHF), 
although the results have been less accurate in elderly patients and in 
women.(25, 26) A BNP of > 100pg/mL has been shown to provide 
relatively high sensitivity (89%) and specifi city (73%) for diagnosing 
HF.(7, 27)  From a cost perspective, the unit cost of BNP is disproportionately 
more expensive compared to ECG but, due to differences in sensitivity 
and specifi city in detecting HF, BNP becomes equally cost-effective as 
ECG.(7) These authors report that the gold standard strategy of 
traditional echocardiography alone was least cost-effective for screening, 
supporting that the ECG (or BNP) can be used cost-effectively for 
screening. Acknowledging the fi nancial cost of treating and managing 
HF, the ECG clearly plays an important role. It may play an even greater 
role in low to middle income countries with a greater pool of individuals 
with more advanced forms of HF and where the cost constraints of 
using expensive bio-markers is more limited.
Pending further analyses to determine the sensitivity, specifi city and 
positive predictive accuracy of the 12-lead ECG relative to gold 
standard echocardiography, these preliminary data indicate a potential 
role for the 12-lead ECG in any systematic screening program for HF in 
Soweto (and other communities). In the Heart of Soweto study, 
echocardiographic assessment was performed in all patients to 
determine ventricular function and functional abnormalities. However, 
the purpose of this paper was to highlight the ECG abnormalities 
independently of echocardiography.  A correlation of the two measures 
will be performed in the near future. 
TABLE 2:  Axis and rhythm characteristics in this HF cohort
Axis
Normal axis 511 (68%)
Left axis deviation 107 (14%)
Right axis deviation 130 (17%)
Extreme deviation    2 (0.2%)
Indeterminate     3 (0.3%)
Rhythm
Sinus Rhythm  475 (63%)
Sinus Tachycardia 198 (26%)
Sinus Bradycardia   13 (1.7%)
Atrial fi brillation/fl utter (persistent)   52 (6.8%)
Heart block     3 (0.3%)
Junctional arrhythmia     5 (0.6%)
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